Groin node lymphadenectomy in vulva cancer carries a substantial risk of morbid sequelae. Sentinel lymph node (SLN) mapping is a valid alternative in patients with squamous cancer of diameter <4 cm and nonsuspicious lymph nodes. SLN are mapped according to the combined technique of radioscintigraphy using technetium-labelled colloid and blue dye. We describe early extranodal recurrence in 2 patients undergoing SLN mapping. They had lymph node metastases at their original dissection. We question whether rapid lymph flow promoted by injection of colloid and dye could cause retrograde flow of cancer cells along the lymphatics draining from the pubis to the groin and extravasation of cancer cells into the dermis since these metastases arose anterior to the pubis and medial to the groin. These recurrence sites were more medial and cephalad than would be expected for skin bridge metastasis. CT imaging shows the metastases are within the dermis. No lymphatic tissue was identified around these subcuticular cancer deposits at repeat resection. Body wall extension occurs in recurrent vulva cancer, but we never saw such an early recurrence when full inguinofemoral lymphadenectomy without SLN was the standard approach. These 2 cases raise a caveat in the application of SLN mapping in vulva cancer, especially when metastasis is detected on SLN as the afferent channels to the lymph nodes may be already blocked or flow impaired by the tumour.

Keywords:
Vulva cancer, Sentinel lymph nodes, Subcutaneous abdominal wall metastases
1.
Ansink AC, van Tinteren H, Aartsen EJ, Heintz AP: Outcome, complications and follow-up in surgically treated squamous cell carcinoma of the vulva 1956-1982. Eur J Obstet Gynecol Reprod Biol 1991;42:137-143.
2.
Gaarenstroom KN, Kenter GG, Trimbos JB, Agous I, Amant F, Peters AA, et al: Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer 2003;13:522-527.
3.
Kamran M, O'Toole F, Meghen K, Wahab A, Saadeh F, Gleeson N: Whole-body [18F]fluoro-2-deoxyglucose positron emission tomography scan as combined PET-CT staging prior to planned radical vulvectomy and inguinofemoral lymphadenectomy for squamous vulvar cancer: a correlation with groin node metastasis. Eur J Gynaecol Oncol 2013;35:230-235.
4.
Levenback C: Intraoperative lymphatic mapping and sentinel node identification: gynecologic applications. Recent Results Cancer Res 2000;157:150-158.
5.
Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, et al: Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008;26:884-889.
6.
Stehman FB, Bundy BN, Thomas G, Varia M, Okagaki T, Roberts J, et al: Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1992;24:389-396.
7.
Oonk MH, van Hemel BM, Hollema H, de Hullu JA, Ansink AC, Vergote I, et al: Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010;11:646-652.
8.
de Hullu JA, Hollema H, Piers DA, Verheijen RH, van Diest PJ, Mourits MJ, et al: Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000;18:2811-2816.
9.
Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
10.
Alex JC, Weaver DL, Fairbank JT, Rankin BS, Krag DN: Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol 1993;2:303-308.
11.
Hampl M, Kueppers V, Bender HG: Single large inguinal lymph node metastasis in human papillomavirus-induced early invasive vulvar cancer of the anterior fourchette in two young women. Gynecol Obstet Invest 2009;67:42-45.
12.
de Melo Maia B, Munhoz Cestari F, Lavorato-Rocha AM, Sant'Ana Rodrigues I, Baiocchi G, Cardoso Guimaraes G, et al: Characterization of sociodemographic and clinicopathological features in Brazilian patients with vulvar squamous cell carcinoma. Gynecol Obstet Invest 2013;75:53-60.
13.
Tanis PJ, Nieweg OE, Valdes Olmos RA, Kroon BB: Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg 2001;192:399-409.
14.
Gleeson NC, Hoffman MS, Cavanagh D: Isolated skin bridge metastasis following modified radical vulvectomy and bilateral inguinofemoral lymphadenectomy. Int J Gynecol Cancer 1994;4:356-358.
15.
Rose PG: Skin bridge recurrences in vulvar cancer: frequency and management. Int J Gynecol Cancer 1999;9:508-511.
16.
Woelber L, Eulenburg C, Choschzick M, Kruell A, Petersen C, Gieseking F, et al: Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment. Int J Gynecol Cancer 2012;22:503-508.
17.
Gadducci A, Cionini L, Romanini A, Fanucchi A, Genazzani AR: Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol 2006;60:227-241.
18.
Wong SY, Hynes RO: Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle 2006;5:812-817.
19.
Jacquet P, Averbach AM, Stephens AD, Sugarbaker PH: Cancer recurrence following laparoscopic colectomy. Report of two patients treated with heated intraperitoneal chemotherapy. Dis Colon Rectum 1995;38:1110-1114.
20.
Shepherd JH, Carter PG, Lowe DG: Wound recurrence by implantation of a borderline ovarian tumour following laparoscopic removal. Br J Obstet Gynaecol 1994;101:265-266.
21.
van Dam PA, DeCloedt J, Tjalma WA, Buytaert P, Becquart D, Vergote IB: Trocar implantation metastasis after laparoscopy in patients with advanced ovarian cancer: can the risk be reduced? Am J Obstet Gynecol 1999;181:536-541.
22.
Walsh JE, Lathers DM, Chi AC, Gillespie MB, Day TA, Young MR: Mechanisms of tumor growth and metastasis in head and neck squamous cell carcinoma. Curr Treat Options Oncol 2007;8:227-238.
23.
Coulter J, Gleeson N: Local and regional recurrence of vulval cancer: management dilemmas. Best Pract Res Clin Obstet Gynaecol 2003;17:663-681.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.